Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists
Author:
Funder
Ministry of Health-Ricerca corrente
Publisher
Elsevier BV
Subject
Pharmacology
Reference200 articles.
1. Hypertension in Diabetes Study (HDS): prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complication;J. Hypertension,1993
2. Diabetes mellitus and hypertension: a dual threat;Oktaya;Curr. Opin. Cardiol.,2016
3. Type 2 diabetes mellitus and hypertension: an update;Lastra;Endocrinol. Metab. Clin. North Am.,2014
4. Cross-talk between insulin and angiotensin signaling systems;Velloso;Proc. Natl. Acad. Sci. U.S.A.,1996
5. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk;Folli;J. Clin. Invest.,1997
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile;Expert Opinion on Drug Safety;2024-05-13
2. Effect of GLP-1 Receptor Agonist on Ischemia Reperfusion Injury in Rats with Metabolic Syndrome;Pharmaceuticals;2024-04-19
3. Antihypertensive effect of Dapagliflozin in Type II diabetic patients with Hypertension;Research Journal of Pharmacy and Technology;2024-02-20
4. Is Tirzepatide the New Game Changer in Type 2 Diabetes?;Endocrines;2024-02-01
5. Sociodemographic disparities in GLP-1RA and SGLT2i use among US adults with type 2 diabetes: NHANES 2005-March 2020;Current Medical Research and Opinion;2024-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3